FTC Releases Second Interim Staff Report on Prescription Drug …

1 day ago · The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty generic drugs, including significant price markups by PBMs for cancer, …

$7
OFF

FTC Says Pharmacy Benefits Managers Marked-up Generic Drug …

2 weeks from now

1 day ago · Several of the biggest US pharmacy benefit managers have generated more than $7.3bn in revenue by charging “enormous mark-ups” for drugs treating cancer and HIV, …

ft.com

$7
OFF

FTC Doubles Down On PBM Criticism In New Report

2 weeks from now

12 hours ago · A new FTC report claims that pharmacy benefit managers generated $7.3bn by marking up specialty ... it has reinforced those claims with a second, highly critical report. ...

pharmaphorum.com

FAQs about FTC Releases Second Interim Staff Report on Prescription Drug … Coupon?

Will the FTC release a report on Big pharmacy benefit manager tactics?

ARLINGTON, Va., Jan. 15, 2025 /PRNewswire/ -- The National Association of Chain Drug Stores is praising the Federal Trade Commission's (FTC) unanimous, 5-0, vote on Monday to release the second interim staff report on the FTC's study of big pharmacy benefit manager (PBM) tactics. ...

Will FTC release interim report on pharmacy benefit managers?

Lawmakers urge FTC to release interim report on pharmacy benefit managers ahead of open meeting. ...

Did big pharmacy benefit manager tactics increase patient drug spending?

Plan sponsor and patient drug spending increased significantly. The National Association of Chain Drug Stores is praising the Federal Trade Commission's (FTC) unanimous, 5-0, vote on Monday to release the second interim staff report on the FTC's study of big pharmacy benefit manager (PBM) tactics. ...

Did pharmacy benefit managers 'hike costs' for'speciality generic drugs'?

The antitrust regulator found the pharmacy benefit managers marked up “numerous” speciality generic drugs distributed at their groups’ own pharmacies by thousands of per cent. The companies “hiked costs for a wide range of life-saving drugs, including medications to treat heart disease and cancer”, FTC chair Lina Khan said. ...

Did pharmacy benefit managers hike costs for lifesaving drugs?

“The FTC staff’s second interim report finds that the three major pharmacy benefit managers hiked costs for a wide range of lifesaving drugs, including medications to treat heart disease and cancer,” said FTC Chair Lina Khan in a statement Tuesday. ...